recombinant Hsp70 based vaccine (Lomonosov Moscow State University)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namerecombinant Hsp70 based vaccine (Lomonosov Moscow State University)
Drug Alias NameN/A
ClassificationVaccinesBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionHSP70 heat-shock proteins modulators
TargetsHSP70 heat-shock proteins
Therapy Area/IndicationsNeoplasmsVirus DiseasesBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLomonosov Moscow State University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLomonosov Moscow State University
Active IndicationsN/A
Inactive IndicationsNeoplasmsVirus DiseasesBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A